Targeting EFHD1 Calcium-Dependent Organellar Contact Stabilization to Prevent Hepatic Injury

Article Impact Level: HIGH
Data Quality: STRONG
Summary of  The Journal of Clinical Investigation. https://doi.org/10.1172/JCI204023
Dr. David R. Eberhardt et al.

Points

University of Utah researchers identified EFHD1 as a calcium-dependent protein that stabilizes endoplasmic reticulum and mitochondrial contacts to drive metabolic-associated steatohepatitis.
Upregulated EFHD1 causes excessive mitochondrial fragmentation under high-fat conditions, leading to cytoplasm-directed leakage of double-stranded RNA and inappropriate antiviral protein kinase R activation.
Preclinical studies demonstrated that blocking EFHD1 expression reduced key indicators of liver inflammation and tissue scarring by thirty to sixty percent in mouse models.
Mendelian randomization analyses in humans supported a direct causal relationship between genetic EFHD1 variants, antiviral stress response activation, and progressive hepatocyte injury.
Laboratory mice lacking EFHD1 maintained normal metabolic function, physical activity, and weight gain, indicating high safety margins for future EFHD1-targeted human clinical therapeutics.

Summary

This study evaluated the mechanisms driving hepatocyte injury and progression in metabolic-associated steatohepatitis (MASH), a condition affecting hundreds of millions worldwide. Led by David Eberhardt and Dipayan Chaudhuri at University of Utah Health and published in the Journal of Clinical Investigation, the investigation focused on EF-Hand Domain Family Member D1 (EFHD1), a calcium-dependent actin crosslinker identified in human genome-wide association studies linked to liver injury rather than primary lipid accumulation. The research sought to clarify how EFHD1 regulates organellar contact sites and downstream cellular stress responses under nutrient excess.

Mechanistic analyses revealed that EFHD1 stabilizes endoplasmic reticulum–mitochondria contact sites (ERMCS) by detecting local calcium release and inter-organellar proximity. In diet- and drug-induced MASH models, excess lipid exposure drove upregulation of EFHD1, causing excessive contact persistence and pathological mitochondrial fragmentation. This structural destabilization permitted the leakage of mitochondrial double-stranded RNA into the cytoplasm, triggering a maladaptive, antiviral protein kinase R (PKR)-associated stress response. Genetic deletion or pharmacological inhibition of EFHD1 reduced objective measures of hepatic inflammation and scarring by approximately 30% to 60% across mouse models and human liver organoid systems.

Genetic knockout mouse models lacking EFHD1 exhibited elongated mitochondrial morphology without adverse alterations in baseline activity levels, body weight, or general lipid metabolism. Mendelian randomization in humans further supported a causal relationship between EFHD1 signaling, antiviral stress activation, and clinical liver injury. The authors conclude that EFHD1 serves as a critical calcium-dependent ERMCS stabilizer driving hepatocyte-intrinsic injury, presenting a complementary therapeutic target alongside lipid-lowering agents to prevent end-stage liver damage.

Link to the article: https://www.jci.org/articles/view/204023

References

Eberhardt, D. R., Rekate, E. C., Masini, Y. B., Duron, H. E., Mollinedo, D., Velarde, A. M., Stucki, D., Price, T. R., Lee, S. H. J., Balderas, E., Rai, N. K., Bratt, A. R., Balynas, A. M., Stubben, C. J., Bia, R., Maity, S., Hartel, N., Yin, X., Corbin, A., … Chaudhuri, D. (2026). Excessive EFHD1-dependent ER-mitochondrial contacts drive a maladaptive antiviral response in metabolic liver disease. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI204023